Pregnancy and contraceptive use among women participating in the FEM-PrEP trial
Data from the FEM-PrEP trial was analyzed to evaluate contraceptive use, pregnancy incidence, and study drug adherence by contraceptive method. The results found that women using combined oral contraceptives, particularly new users, were more likely to become pregnant and less likely to adhere to study product than injectable users.
Resource Details
- Study Type
- Observational study
- Year
- 2015
- Population
- HIV-uninfected women
- Author
- Callahan R, Nanda K, Kapiga S, Malahleha M, Mandala J, Ogada T, Van Damme L, Taylor D
More Publications & Resources
PrEP and PEP Guidelines-Zambia
PrEP Lenacapavir Implementation Guidelines
Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics
Lenacapavir Provider Tools and Job Aids
PrEP Drug Interactions
Zambia PrEP Training Materials for Clinicians and Community Mobilisers
HIV Prevention Ambassador Training Package and Toolkit
Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection
National Guidelines for the Management of HIV and AIDS
No results found.